Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.

Slides:

Advertisements

Similar presentations

Preventing Strokes One at a Time Acute Interventions and Management 2009.

Advertisements

10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.

UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,

Should developing countries continue to use older drugs for essential hypertension? A prescription survey in South Africa suggested that prescribers were.

Thiazide-Like/Calcium Channel Blocker (CCB) Agents: A Major Combination for Hypertension Management Safar M, Blacher J. Am J Cardiovasc Drugs. 2014; DOI.

Thiazide diuretics, Potassium, and the Development of Diabetes A Quantitative Review Hypertension2006_219.

NADIA ISLAM, PHD SECTION FOR HEALTH EQUITY, DEPARTMENT OF POPULATION HEALTH NYU SCHOOL OF MEDICINE Community Health Worker Models in Asian American Communities.

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.

Hypertension In The Stroke Patient

David Antecol, M.D., FACC, FASH, FRCP(C) Specialist in Clinical Hypertension (American Society of Hypertension) Disclosures: None.

Copyright © 2015 by the American Osteopathic Association.

Blood Glucose, Lipids, and Coronary Artery Disease: Emerging Strategies for Multimechanistic Treatment.

2012 ADA Clinical Practice Guidelines Therapies for DM- Type 2

Upfront Combination Therapy vs Step-Up Approach for PAH:

Aaron P Kithcart Giuseppe Curigliano Joshua A. Beckman Cardio-Oncology

What’s New in the 2013 ESC/ESH Hypertension Guideline

The Canadian Hypertension Education Program expedited assessment and diagnosis of patients with hypertension: Focus on validated technologies for blood.

Copyright © 2008 American Medical Association. All rights reserved.

Aliskiren and Valsartan for Antihypertensive Therapy Trial

Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.

Primary Efficacy End Point.

51st Annual Scientific Session for the LIFE Investigators

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

UNDERSTANDING RISK STRATIFICATION IN PAH:

Appropriate Stroke Prevention Strategies in Atrial Fibrillation

Angiotensin as a Vasopressor in Vasodilatory Shock

MANAGING GLAUCOMA:.

Modern Strategies for Basal Insulin Use in T2D

Patient Case Discussions in T2D: What Intensification Plan Is Best?

Select Topics in Cardiovascular Medicine

Managing Complex Hypertension: What Every Physician Should Know

How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients

Resistant Hypertension

SGLT2 Inhibitors in the Modern Era: Why and Where?

Managing Hard-To-Treat Hypertension: What Every Physician Should Know

Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy: Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene? Sumeet Gupta, MPharm, PhD,

Surveying the Safety of NOACs in the Real World

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

Hypertension Guidelines

Talking to Patients About Diabetes Management

Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.

Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.

Program Overview. Treatment Options for Post-MI patients with LVD – are all ACE Inhibitors Equal?

Practical Strategies to Reduce HF Hospitalizations in African American Patients.

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

Controlling High Blood Pressure

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

The Road to Quality Improvement in HER2-Positive Breast Cancer

Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?

Improving Outcomes in AF: Do the NOACs Hold Their Promise In The Real World?

Guidelines for the Older Adult With CKD

Statins, Obesity, and Hyperlipidemia

Controlling Elevated Blood Pressure

Iron Deficiency in Heart Failure

Pharmaceutical care planning 2 Ola Ali Nassr

Practical Strategies for Getting Patients With Diabetes to Lipid Goal

Medication adherence and activity patterns underlying uncontrolled hypertension: Assessment and recommendations by practicing pharmacists using digital.

William T. Abraham et al. JCHF 2015;3:

Optimal Treatment of PAH

AMD Therapy: Where Are We Now and Where Are We Going?

VTE Treatment and Secondary Prevention VTE Treatment Trials Initial Dosing.

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

Algorithm for the management of patients with prediabetes or T2DM and definite NASH. This suggested therapeutic algorithm is based on the safety and efficacy.

End point Valsartan Valsartan+HCTZ p

Improving Management of Acute HTN in Patients With Stroke

RAASi Enabling in the Modern Era

PCSK9 Inhibitors and Real-World Evidence

Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive.

Presentation transcript:

Strategies to Improve Adherence and Persistence in the Treatment of Hypertension

Hypertension A Major Public Health Crisis

20-Year Trends in Hypertension in the US 1988–2008

Hypertension African Americans

Contrasts in Goal BP Recommendations

Systolic Blood Pressure Intervention Trial (SPRINT)

Adherence

Strategic Approach to Adherence

Canadian Hypertension Guidelines Recommendations

ESC Hypertension Treatment Recommendations

Starting Therapy With Combination Therapy

Different Effects of β-Blockers on NO-Mediated Endothelial Dysfunction in Patients With HTN

Efficacy of Nebivolol and Valsartan as Fixed-Dose Combination

Change in Glucose and Lipid Parameters in Patients With Diabetes Nebivolol Monotherapy

Abbreviations

Abbreviations (cont)